The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Quantum, Workforce Issues Lead FDA’s Digital Transformation
The FDA is taking a proactive approach to its digital transformation efforts that its tech leaders highlighted in a new IT strategy.
14m listen -
Storytelling Miniseries: The Skill that Can Unite Cross-Generational Teams
The third episode in this Storytelling Miniseries for federal leaders discusses bridging gaps across generations in the workplace.
20m listen -
AI Startups Help Detect, Prevent Common Cancers in Women
Brittany Connors, SBIR director of investor relations at NCI, discussed how she is working with startups to develop the technology that better detects breast cancer and cervical cancer in their early stages.
23m listen -
How Emerging Tech Removes Burdens at Nation’s Borders for CBP Officers
CBP Acting Executive Assistant Commissioner Diane Sabatino discussed her vision for emerging technologies the agency is adopting at the nation’s ports.
23m listen